SCOPUS 정보 검색 플랫폼

Volumn 26, Issue 2, 1997, Pages 449-450

Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: Role of type and schedule of alpha interferon [3]

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

CHRONIC HEPATITIS; DRUG EFFICACY; HEPATITIS C; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031054021 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-8278(97)80069-4 Document Type: Letter

Times cited : (6)

References (6)

1
- 0028936256
- Breakthrough during recombinant alfa-interferon therapy in patients with chronic hepatitis C virus infection: prevalence, etiology and management
- L Roffi G Colloredo Mels G Antonelli G Bellati F Panizzuti A Piperno M Pozzi D Ravizza G Angeli F Dianzani G Mancia Breakthrough during recombinant alfa-interferon therapy in patients with chronic hepatitis C virus infection: prevalence, etiology and management Hepatology 21 1995 645 649
- (1995) Hepatology , vol.21 , pp. 645-649
- Roffi, L¹ Colloredo Mels, G² Antonelli, G³ Bellati, G⁴ Panizzuti, F⁵ Piperno, A⁶ Pozzi, M⁷ Ravizza, D⁸ Angeli, G⁹ Dianzani, F¹⁰ Mancia, G¹¹

2
- 0028088836
- Treatment of chronic hepatitis C with recombinant human interferon alpha-2a: results of a randomized controlled clinical trial
- G Diodati P Bonetti F Noventa C Casarin Rugge M S Scaccabarozzi A Tagger L Pollice F Tremolada C Davite G Realdi A Ruol Treatment of chronic hepatitis C with recombinant human interferon alpha-2a: results of a randomized controlled clinical trial Hepatology 19 1994 1 5
- (1994) Hepatology , vol.19 , pp. 1-5
- Diodati, G¹ Bonetti, P² Noventa, F³ Casarin, C⁴ M, Rugge⁵ Scaccabarozzi, S⁶ Tagger, A⁷ Pollice, L⁸ Tremolada, F⁹ Davite, C¹⁰ Realdi, G¹¹ Ruol, A¹²

3
- 0029002512
- The breakthrough phenomenon during alfa-interferon therapy of chronic hepatitis C: incidence, management and outcome
- E Lebovics J Lantin G Chaurushia BM Dworkin A Casellas WS Rosenthal The breakthrough phenomenon during alfa-interferon therapy of chronic hepatitis C: incidence, management and outcome Am J Gastronterol 90 1995 951 954
- (1995) Am J Gastronterol , vol.90 , pp. 951-954
- Lebovics, E¹ Lantin, J² Chaurushia, G³ Dworkin, BM⁴ Casellas, A⁵ Rosenthal, WS⁶

4
- 0028144718
- Continuous versus intermittent therapy for chonic hepatitis C with recombinant interferon alfa-2a
- F Negro M Baldi A Mondardini G Leandro M Chaneac P Manzini ML Abate F Zahm G Dastoli M Ballarè J-C Ryff G Verme F Bonino Continuous versus intermittent therapy for chonic hepatitis C with recombinant interferon alfa-2a Gastroenterology 107 1994 479 485
- (1994) Gastroenterology , vol.107 , pp. 479-485
- Negro, F¹ Baldi, M² Mondardini, A³ Leandro, G⁴ Chaneac, M⁵ Manzini, P⁶ Abate, ML⁷ Zahm, F⁸ Dastoli, G⁹ Ballarè, M¹⁰ Ryff, J-C¹¹ Verme, G¹² Bonino, F¹³

5
- 85114538723
- Breakthrough during therapy with natural interferon alpha for chronic hepatitis C
- G Bellati L Roffi G Antonelli G Colloredo M Currenti A Bellobuono F Bissoli M D'Aquino A Redaelli G Ideo F Dianzani G Mancia C.H.S.G. Breakthrough during therapy with natural interferon alpha for chronic hepatitis C Hepatology 22 1995 114A part 2
- (1995) Hepatology , vol.22 , pp. 114A
- Bellati, G¹ Roffi, L² Antonelli, G³ Colloredo, G⁴ Currenti, M⁵ Bellobuono, A⁶ Bissoli, F⁷ D'Aquino, M⁸ Redaelli, A⁹ Ideo, G¹⁰ Dianzani, F¹¹ Mancia, G¹² C.H.S.G.¹³

6
- 0025759062
- Neutralizing antibodies to Interferon-alpha: relative frequency in patients treated with different interferon preparation
- G Antonelli M Currenti O Turriziani F Dianzani Neutralizing antibodies to Interferon-alpha: relative frequency in patients treated with different interferon preparation J Infect Dis 163 1991 882 885
- (1991) J Infect Dis , vol.163 , pp. 882-885
- Antonelli, G¹ Currenti, M² Turriziani, O³ Dianzani, F⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.